Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2026-05-14 17:00:05 ET · period of report 2026-05-13 · accession 0001310715-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-14 17:00 | 2026-05-13 | CAPR | Litvack Frank | Dir | M - OptEx | $1.39 | +3,937 | 133.8K | +3% | +$5,472 |
| D | 2026-05-14 17:00 | 2026-05-13 | CAPR | Litvack Frank | Dir | M - OptEx | $0.00 | -3,937 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-13 | M | A | 3,937 | $1.39 | 133,776 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-13 | M | D | 3,937 | $0.00 | 0 | D | $1.39 · — to 2026-06-02 | 3,937 Common Stock | (F2) This option was granted on June 2, 2016 and was previously reported as covering 39,375 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. (F3) 1,750 shares vested immediately on June 2, 2016. The remaining shares vested on December 31, 2016. |